Exploiting tumor microenvironment-mediated mechanisms of therapeutic resistance in Ras/MAPK-altered solid cancers
Combined BRAF/MEK and PSGL-1 targeting provides a durable anti-tumor response through enhanced functionality and a memory-like phenotype in CD8⁺ T cell subsets.
Olivia S. El Naggar, Gabriele Romano
· 0 citations